share_log

Indiva FY22 Revenue Grows 6.8% To A Record $25.7M, Provides Outlook

Indiva FY22 Revenue Grows 6.8% To A Record $25.7M, Provides Outlook

Indiva 22財年收入增長6.8%,達到創紀錄的2570萬美元,提供展望
Benzinga ·  2023/04/18 20:20

$INDIVA LIMITED (NDVAF.US)$ achieved a record net revenue for the year ended December 31, 2022 of CA$34.4 million ($25.7 million) versus CA$32.2 million for the year ended December 31, 2021, representing a 6.8% year-over-year increase. Net revenue growth was driven primarily by new product introductions offset by lower sales of Wana Sour Gummies.

$INDIVA LIMITED (NDVAF.US)$ 實現了 創紀錄的淨收入 截至2022年12月31日的財年 的 3,440 萬加元 (2570萬美元),而截至2021年12月31日的年度爲3,220萬加元,相當於 同比增長 6.8%。淨收入增長主要是由新產品的推出所推動的,但被銷售額的減少所抵消 瓦納酸味軟糖

Q4 2022 Financial Highlights

2022 年第四季度財務摘要

  • Net revenue in Q4 2022 was CA$9.3 million, representing a 15.0% sequential increase from Q3 2022, and a 0.7% decrease year-over-year from Q4 2021.

  • Gross profit before fair value adjustments, impairments and one-time items was CA$2.7 million, or 29.3% of net revenue, versus 28.9% in Q3 2022 and 31.5% in Q4 2021.

  • Adjusted EBITDA was a loss of CA$556,600, versus a loss of CA$575,800 in Q4 2021.

  • Loss and comprehensive loss was CA$2.8 million compared to CA$4.2 million in Q4 2021.

  • 2022 年第四季度的淨收入爲 930 萬加元,比 2022 年第三季度連續增長 15.0%,比 2021 年第四季度同比下降 0.7%。

  • 扣除公允價值調整、減值和一次性項目前的毛利爲270萬加元,佔淨收入的29.3%,而2022年第三季度爲28.9%,2021年第四季度爲31.5%。

  • 調整後的息稅折舊攤銷前利潤爲虧損556,600加元,而2021年第四季度的虧損爲575,800加元。

  • 虧損和綜合虧損爲280萬加元,而2021年第四季度爲420萬加元。

Fiscal Year 2022 Performance

2022 財年業績

  • Gross margin before fair value adjustments and impairments improved slightly to a record CA$10.4 million or 30.2% of net revenue versus CA$9.7 million or 30.1% of net revenue for the year ended December 31, 2021.

  • Adjusted EBITDA decreased to a loss of CA$1.6 million versus a loss of CA$495,500 last year.

  • Impairment and one-time charges for the year totaled CA$2.2 million.

  • Loss and comprehensive loss was CA$10.9 million compared to a loss of CA$15.2 million last year.

  • 公允價值調整和減值前的毛利率略有提高,達到創紀錄的1,040萬加元,佔淨收入的30.2%,而截至2021年12月31日的年度爲970萬加元,佔淨收入的30.1%。

  • 調整後的息稅折舊攤銷前利潤降至虧損160萬加元,而去年爲虧損495,500加元。

  • 該年度的減值和一次性費用總額爲220萬加元。

  • 虧損和綜合虧損爲1,090萬加元,而去年的虧損爲1,520萬加元。

"We are pleased to report record revenue and record gross profit for the fiscal year 2022. Indiva continued to be the national market share leader in edibles throughout 2022. In the fourth quarter, as per Hifyre data, Indiva was ranked 13th out of 164 licensed producers by consolidated market share across all categories in the five major provinces where edibles sales are permitted. On a units shipped basis, Indiva ranked 3rd nationally in the fourth quarter, making Indiva one of the most important suppliers to provincial wholesalers and retailers. Our distribution reaches all 13 provinces and territories in Canada, as well as multiple medical partners, including Tilray (NASDAQ:TLRY), with whom Indiva recently signed an agreement to provide its industry leading edibles products to patients registered on their medical platform," stated Niel Marotta, president and CEO of Indiva.

“我們很高興報告2022財年創紀錄的收入和創紀錄的毛利。在整個2022年,Indiva一直是全國零食市場份額的領導者。根據Hifyre的數據,在第四季度,在允許銷售零食的五個主要省份中,按所有類別的合併市場份額計算,Indiva在164家持牌生產商中排名第13位。按出貨量計算,Indiva在第四季度排名全國第三,使Indiva成爲省級批發商和零售商最重要的供應商之一。我們的配送範圍覆蓋加拿大所有 13 個省和地區,以及多個醫療合作伙伴,包括 Tilray (納斯達克股票代碼:TLRY),Indiva最近與該公司簽署了一項協議,向在其醫療平臺上註冊的患者提供其行業領先的零食產品。” 尼爾·馬洛塔,Indiva總裁兼首席執行官。

Outlook

外表

  • The company expects that Q1 2023 net revenue will be down slightly on a sequential basis, but higher year-over-year, due to the benefit of broader distribution of new products, offset by lower sales of ingestible extracts.

  • Margins are expected to improve sequentially in Q1 2023 due to the benefit of the implementation of automation in the production and packaging of edible products.

  • Photo: Benzinga edit with photo by Kindel Media on Pexels

    Related News

  • 該公司預計,2023年第一季度的淨收入將連續小幅下降,但同比有所增加,這要歸因於新產品分銷範圍的擴大,被可食用提取物銷售的減少所抵消。

  • 由於可食用產品生產和包裝實現自動化的好處,預計利潤率將在2023年第一季度連續提高。

  • 照片:Benzinga 在 Pexels 上使用 Kindel Media 的照片進行編輯

    相關新聞

Two Cannabis Companies Cease Production Of Certain Extracts Due To Inaccurate Classification

由於分類不準確,兩家大麻公司停止生產某些提取物

Indiva Amends Convertible Debentures, Enters Into Shares For Debt Agreements

Indiva 修改可轉換債券,爲債務協議訂立股份

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論